Invasive fungal infections in the neutropenic cancer patient: Current approaches and future strategies

Andreas H. Groll, Thomas J. Walsh

Research output: Contribution to journalArticlepeer-review

Abstract

Invasive fungal infections are important causes of morbidity and mortality in cancer patients with prolonged neutropenia following dose-intensive chemotherapy or hematopoietic stem cell transplantation. Recent epidemiologic trends indicate a shift toward infections by Aspergillus species, non-albicans Candida species, and previously uncommon fungal pathogens that have decreased susceptibility to current antifungal agents. In the last decade, much progress has been made in establishing disease definitions and paradigms for antifungal intervention and in the design and conduct of interventional clinical trials. This article reviews current approaches to prevention and treatment of opportunistic fungal infections in neutropenic patients and discusses novel approaches to antifungal chemotherapy and supportive measures.

Original languageEnglish (US)
Pages (from-to)326-334
Number of pages9
JournalInfections in Medicine
Volume19
Issue number7
StatePublished - 2002

Keywords

  • Antifungal agents
  • Cancer
  • Mycoses
  • Transplantation

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Invasive fungal infections in the neutropenic cancer patient: Current approaches and future strategies'. Together they form a unique fingerprint.

Cite this